• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.87% Nasdaq Up0.34%

    Infinity Pharmaceuticals, Inc. (INFI)

    -NasdaqGS
    17.32 Down 0.41(2.31%) 4:00PM EST
    |After Hours : 17.32 0.00 (0.00%) 4:47PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   47,114   92,773  
    Cost of Revenue -   -   -  
    Gross Profit -   47,114   92,773  
    Operating Expenses
    Research Development99,760  118,595  108,582  
    Selling General and Administrative27,916  (18,673)22,719  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (127,676) (52,808) (38,528)
    Income from Continuing Operations
    Total Other Income/Expenses Net896  752  327  
    Earnings Before Interest And Taxes(126,780)(52,056)(38,201)
    Interest Expense -  1,908  1,841  
    Income Before Tax(126,780)(53,964)(40,042)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(126,780)(53,964)(40,042)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (126,780) (53,964) (40,042)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (126,780) (53,964) (40,042)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.